Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylases.
Seitz J, Auth M, Prinz T, Hau M, Tzortzoglou P, Schulz-Fincke J, Schmidtkunz K, Baniahmad AA, Willmann D, Metzger E, Hein L, Preissl S, Schüle R, Jung M.
Seitz J, et al. Among authors: hein l.
Arch Pharm (Weinheim). 2024 Oct;357(10):e2400450. doi: 10.1002/ardp.202400450. Epub 2024 Jul 14.
Arch Pharm (Weinheim). 2024.
PMID: 39004853